
Sirio Pharma Co Ltd
SZSE:300791

Dividends
Dividend Yield
Sirio Pharma Co Ltd
Current Yield | |
Min Yield | |
Max Yield | |
Average Yield | |
Median Yield |
Dividend Per Share
Sirio Pharma Co Ltd

Payout Ratio
Sirio Pharma Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Sirio Pharma Co Ltd is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Sirio Pharma Co Ltd
Average Annual Return | 26.1% |
Standard Deviation of Annual Returns | 85.46% |
Max Drawdown | -73% |
Market Capitalization | 5.9B CNY |
Shares Outstanding | 235 870 000 |
Percentage of Shares Shorted |
N/A
|
Stock Splits
Sirio Pharma Co Ltd's latest stock split occurred on Jun 21, 2024
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, Sirio Pharma Co Ltd traded at 35.34 per share. Afterward, the share price was about 26.9.
The adjusted shares began trading on Jun 21, 2024. This was Sirio Pharma Co Ltd's 3rd stock split, following the previous one in Jun 8, 2021.